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Abstract
Currently, the use of optogenetic sensitization of retinal cells combined with activation/inhi-
bition has the potential to be an alternative to retinal implants that would require electrodes
inside every single neuron for high visual resolution. However, clinical translation of optoge-
netic activation for restoration of vision suffers from the drawback that the narrow spectral
sensitivity of an opsin requires active stimulation by a blue laser or a light emitting diode
with much higher intensities than ambient light. In order to allow an ambient light-based
stimulation paradigm, we report the development of a ‘white-opsin’ that has broad spectral
excitability in the visible spectrum. The cells sensitized with white-opsin showed excitability
at an order of magnitude higher with white light compared to using only narrow-band light
components. Further, cells sensitized with white-opsin produced a photocurrent that was
five times higher than Channelrhodopsin-2 under similar photo-excitation conditions. The
use of fast white-opsin may allow opsin-sensitized neurons in a degenerated retina to
exhibit a higher sensitivity to ambient white light. This property, therefore, significantly low-
ers the activation threshold in contrast to conventional approaches that use intense narrow-
band opsins and light to activate cellular stimulation.
Introduction
Optogenetic stimulation provides high temporal precision [1–6], minimal invasiveness [7] and
cellular specificity by introducing light-activatable ion-channels into cells by genetic targeting.
Selective activation of neurons by millisecond (ms)-pulsed blue light has been demonstrated in
culture [5], brain slices, as well as in small animals [8–11]. Currently, the use of optogenetic
sensitization of retinal cells, combined with active light stimulation, has allowed the possibility
of eliminating the requirement of placing electrodes near the retina. This optogenetic activation
method is very promising as it only requires light of moderate intensity (~0.1 mW/mm2) that
can be delivered from a light emitting diode (LED) or laser [1–2]. The present approaches for
optogenetic restoration of vision have used either Channelrhodopsin-2 (ChR2) [12–17] or
Halorhodopsin (NpHR) [18], both of which have narrow spectral excitation bands (e.g. blue
excitation for ChR2 and yellow inhibition for NpHR). However, clinical translation of optoge-
netic activation for visual restoration suffers from the use of microbial opsins that possess nar-
row spectral sensitivities and narrow-band active excitation sources. Thus, all attempts for
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restoring vision by optogenetic stimulation so far have focused on the development and imple-
mentation of an array of intense narrow-band light sources (e.g. LED array [19]) to activate
opsin-sensitized cells in the retina. This has two major limitations. Firstly, increasing the light
intensity to high enough levels to activate chronically narrow-band opsin-expressing cells may
substantially damage residual cellular function that might exist in the diseased or impaired ret-
ina. Secondly, although optogenetic stimulation allows positioning of the active illumination
source outside the eye ball (in contrast to electrical stimulation [20–21]), achieving higher
visual resolution using a micro LED array approach is difficult. In contrast, the use of ambient
light stimulation (in a passive manner) would mitigate these limitations, in addition to elimi-
nating the discomfort associated with wearing bulky active-stimulation prosthetics.
Here, we report the development of a ‘white-opsin’ that has broad spectral excitability in the
visible spectrum. White-opsin-sensitized cells produce a photocurrent that is an order of mag-
nitude higher compared to that generated by ChR2 under similar photo-excitation conditions,
without compromising the fast channel kinetics. The use of fast white-opsin may increase
photosensitivity to ambient white light for opsin-sensitized neurons in a degenerated retina.
Such an effect is predicted to significantly lower neuronal activation thresholds in contrast to
conventional approaches that utilize intense, narrow-band light to actively stimulate cells.
Materials and Methods
Construction of white-opsin
The opsins ChR2 (Stanford University), C1V1 (Stanford University) and ReaChR (UCSD)
have spectrally-separated photo-activation peaks at 460 nm (blue), 540 nm (green) and 600
nm (red) respectively with a band width of ~90 nm [22–23]. Fig 1A shows the normalized acti-
vation spectra of these three narrow-band opsins [23]. By combining all three opsins, the con-
struction of a “white-opsin” with a broad-band activation spectrum that is stimulated by white
light should be possible. To test this, MultiSite Gateway1 Technology [24] was used to fuse
multiple opsin-encoding genes, ChR2, C1V1 and ReaChR, under the control of a cytomegalo-
virus (CMV) promoter (Figs 1 and 2). A plasmid map of this white-opsin is shown in Fig 1B.
MultiSite Gateway1 Technology [25–27], which employs site-specific re-combinational
cloning, was used to simultaneously clone multiple DNA fragments in a defined order. Four
PCR products, each containing a gene of interest flanked by specific attB or attBr sites, and
four donor vectors were used in separate BP recombination reactions to generate four entry
clones. The four entry clones and the destination vector, pDEST™ R4-R3 Vector II were used
together in a LR recombination reaction to create the white-opsin expression plasmid. Suitable
primers were used to remove the stop codon from the respective genes during PCR amplifica-
tion. Opsin plasmid maps containing ChR2-YFP (Yellow Fluorescent Protein), C1V1-YFP,
ReaChR-Citrine, as well as the CMV promoter sequence are shown in S1 Fig. This figure also
shows the final expression vector for the white-opsin with the attB sites created by PCR ampli-
fication. To ensure the white-opsin fusion-protein was intact and functional, each component
(i.e. ChR2, C1V1 and ReaChR) was confirmed by molecular analysis and experimentally by
measuring the inward photocurrent generated by activation at particular wavelength.
Molecular analysis of white-opsin
Specific primers were designed and used to check for sequence fidelity by running a sequencing
reaction on a 3130xL Genetic Analyzer, after overnight incubation of the plasmid with the
primer. Western blot experiments were performed to confirm expression of the white-opsin
protein by using an anti-YFP antibody (Santa Cruz Biotechnology). Loading controls were also
included in the western blots by using antibodies to GAPDH (CALBIOCHEM) and β-Actin
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Fig 1. White-opsin construct and broad-band activation. (a) Schematic of normalized activation spectra of narrow-band opsins (ChR2, C1V1 and
ReaChR), redrawn from published literature [22–23]. (b) Schematic vector map of the broad-band activatable white-opsin coding region made by fusing three
opsin genes of interest encoding ChR2, C1V1 and ReaChR for blue, green and red sensitivity, respectively. The expression of the fusion protein is driven by
a CMV promoter. The fusion protein also contains domains that correspond to two different reporter proteins, enhanced yellow fluorescent protein (EYFP)
Broad-Band Activatable White-Opsin
PLOS ONE | DOI:10.1371/journal.pone.0136958 September 11, 2015 3 / 13
(Cell Signaling). The molecular weight of the white-opsin (~150 kD) is consistent with that
estimated using an open source online tool (http://www.sciencegateway.org/tools/proteinmw.
htm).
Cell culture and opsin transfection
10,000 HEK293 cells (ATCC) were cultured in a 35 mm petridish and maintained in
DMEM/F-12 (Life Technologies), supplemented with 10% fetal bovine serum (Sigma-Aldrich),
0.2 mg/mL streptomycin (Sigma-Aldrich) and 200 U/mL penicillin (Sigma-Aldrich). The cul-
tures were maintained at 37°C in a 5% CO2 humidified atmosphere. Two days after plating, the
cells were transfected with ChR2 or white-opsin constructs (1 μg/ml) using lipofectamine (Life
Technologies). After a further 24 hours, reporter protein fluorescence (i.e. Citrine, YFP) was
visualized under suitable illumination to identify cells for patch-clamp electrophysiology that
expressed the transgene (Fig 2). Prior to light activation, cells were loaded with all-trans retinal
(ATR; 1 μM, Sigma-Aldrich) for at least 6 hours before conducting downstream experiments.
HEK293 cells (without opsin transfection) were cultured separately as negative controls.
and Citrine. (c) Bands showing control (extracted from HEK293 cells not transfected with white-opsin) and white-opsin (extracted from HEK293 cells
transfected with white-opsin).
doi:10.1371/journal.pone.0136958.g001
Fig 2. Expression of white-opsin in mammalian cells. (a) Representative confocal image of a white-opsin-transfected HEK293 cell without nuclear
staining. Scale bar: 5 μm. (b) Confocal fluorescence image of white-opsin transfected live HEK293 cells stained with nuclear staining dye Hoechst 33242. (c)
Confocal image of multiple HEK293 cells showing white-opsin expression. Scale bar: 10 μm. (d) Reporter fluorescence intensity along lines across
representative cells (shown in c, dotted blue lines) showing localized expression of white-opsin at the plasmamembrane. a.u. = arbitrary units.
doi:10.1371/journal.pone.0136958.g002
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Optogenetic stimulation
Broad-band white light from a 150 W halogen lamp (FO-150, Chiu Technical Corporation)
was delivered to the sample by a multimode optical fiber for optogenetic stimulation. The sche-
matic setup for evaluating broad spectral excitation of opsin-expressing cells is shown in S2
Fig. The current-controller was used to regulate the intensity of white light. A set of filters
was used in the light path to illuminate the sample with narrow-band blue (490 nm), green
(525 nm) and red (630 nm) light. In order to measure the spectrum of the white light and
the filtered narrow-band light, a spectrometer (Ocean Optics) was used. As compared to the
300 nm bandwidth of the white light, the spectrally-filtered narrow-band lights had band-
widths of 10 nm (Fig 3A). Note that the narrow bandwidth activation lights used were not posi-
tioned at the spectral peak of absorbance (λmax) for each of the component opsins; however,
Fig 3. Quantitative comparison between broad-band and spectrally-filtered narrow-band optogenetic
activation of white-opsin. (a) Spectra of white-light and spectrally-filtered (not intensity-calibrated) narrow-
band lights used for optogenetic activation of white-opsin-expressing cells. Representative inward current
responses of white-opsin-sensitized HEK293 cells stimulated by (b) white, (c) blue, (d) green and (e) red light.
The white light power is fixed and then spectrally-filtered (lower powers for the narrow band measurements).
(f) Measured inward peak-currents for varying spectral excitation of white-opsin-sensitized cells. N = 3
biological replicates (total of five cells, 20 sweeps). Average ± S.D. a.u. = arbitrary units.
doi:10.1371/journal.pone.0136958.g003
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they were within the full width at half maximum (FWHM) range of the activation spectrum
(Fig 1A). Light power output at the sample plane was measured using a power meter (PM
100D, Thorlabs). For wavelength comparison, the intensity of red light was filtered to the rela-
tive intensities of blue and green light using a neutral density filter. The intensity spectral densi-
ties (light intensity/nanometer band) of blue, green, red and white light were kept constant at
0.0004 mW/mm2/nm. This value corresponds to light intensities of 0.004 mW/mm2 for blue,
green and red wavelengths (bandwidth: 10 nm), and 0.12 mW/mm2 for white light (bandwidth:
~300 nm), respectively. An electro-mechanical shutter controlled the exposure (pulse) dura-
tion, which was synchronized by the electrophysiology recording system (Axon Instruments,
Molecular Devices). Opsin-expressing cells were exposed to different light conditions (i.e. blue,
green, red or white light), where the sequence was randomized. For evaluating the effects of
light activation with HEK293 cells expressing the white-opsin, inward currents were recorded
by patch-clamp electrophysiological techniques.
Expression analysis and patch-clamp recording
For analysis of opsin-expression, fluorescence images of reporter fluorescent proteins were
acquired using a charge-coupled device (CCD; Photometrics) coupled to an upright fluores-
cence microscope (Olympus BX 60M). For confirming the localized expression of opsin pro-
tein at the cell membrane, confocal microscopy (Zeiss, LSM 510) of cells was carried out in the
presence of nuclear staining dye Hoechst H33242.
The opto-electrophysiology set up (S2 Fig) consists of an Olympus upright fluorescence
microscope platform with an amplifier system (Axon Multiclamp 700B, Molecular Devices
Inc.). Parameters of the pipette puller were optimized in order to obtain desired borosilicate
micropipettes of resistance from 3 to 5 MO for whole-cell patch-clamp electrophysiology. The
micropipette was filled with a solution containing 130 mM K-Gluoconate, 7 mM KCl, 2 mM
NaCl, 1 mMMgCl2, 0.4 mM EGTA, 10 mMHEPES, 2 mM ATP-Mg, 0.3 mM GTP-Tris and
20 mM sucrose. The electrode was mounted on an XYZ motorized micromanipulator. The
standard extracellular solution contained 150 mMNaCl, 10 mM Glucose, 5 mM KCl, 2 mM
CaCl2, 1 mMMgCl2, buffered with 10 mMHEPES (pH 7.3). The output from the amplifier
was digitized using Digidata (Molecular devices). For electrophysiological recording, the hard-
ware was interfaced with patch-clamp software (pClamp, Molecular Devices). For the activa-
tion of white-opsin-expressing cells, the stimulation beam was delivered by an optical fiber.
For generating and controlling pulses of light, the electro-mechanical shutter in the light path
was interfaced with a computer. Transistor-transistor logic (TTL) pulses of desired frequency
were generated using a Digidata card in order to produce the required pulses of light for activa-
tion. Voltage clamp recordings were done in the dark using randomized fluorescent cells
derived from three independent experiments. Open-source software (PMMicroManager) and
ImageJ (NIH) were used for the acquisition and analysis of fluorescence images, respectively.
In case of light stimulation using same wavelength, 100 ms pulse stimulation and ~1 s resting
time was given between each sweep of electrophysiological recording in cells. For different
color stimulations (blue, green, red or white light), 1 min recovery periods were allowed
between each patch-clamp recording. pClamp 10 (Molecular Devices) software was used for all
patch-clamp data analyses. Two-tailed Student’s t-test and Bonferroni analyses were used to
determine any statistical significant differences in fluorescence and patch-clamp recordings.
Measurement of activation spectrum
A lens and a grating (600 lp/mm) was used (in place of a narrow-band filter, S2 Fig) to disperse
the while light. The grating was rotated to couple light of different wavelengths into the optical
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fiber (S2 Fig). The expression of each component of the white-opsin fusion protein (i.e. ChR2,
C1V1 and ReaChR) was in a 1:1:1 ratio, which was confirmed experimentally by tuning the
activation wavelength and measuring the inward photocurrent.
Results
Molecular analysis of white-opsin for broad-band light activation
Sequencing data for the white-opsin plasmid confirmed that the whole construct size was
~11 kb, whilst BLAST analysis showed matches to each designed opsin sequence. Western blot
analysis confirmed the expression of the white-opsin in HEK293 cells at the expected size of
~150 kD (Fig 1C), whereas no expression was found in negative control lanes despite compara-
ble levels of GAPDH and β-Actin proteins.
White-opsin is expressed in the cell membrane
The expression and trafficking of white-opsin protein to the cell membrane (compared to the
cytoplasm) was quantified by measuring the signal intensity of fluorescent reporters YFP and
Citrine. To rule out any contribution from out-of-focus fluorescence (e.g. from cell membranes
above and below the plane of focus, which might be considered to be intracellular fluorescence
when using an epifluorescence microscope), confocal fluorescence microscopy was carried out.
Fig 2 shows that the reporter protein contained within the white-opsin fusion protein is local-
ized to the cell membrane. No detectable intracellular aggregation was observed, implying that
trafficking of white-opsin protein to the plasma membrane was efficient. Quantitative compar-
isons of white-opsin expression in the plasma membrane compared to intracellular areas were
carried out by measuring the fluorescence intensity along straight lines that traversed a number
of different transfected cells (Fig 2C), where expression levels were shown to be ~6-fold higher
at the membrane (Fig 2D).
Broad-band excitation generates higher photocurrent than narrow-band
activation
Fig 3B shows a representative light-induced inward current in a white-opsin-expressing HEK293
cell upon illumination of broad-band white light (pulse width: 100 ms) at a light intensity of
0.12 mW/mm2. Representative inward current responses of a white-opsin-sensitized HEK293
cell stimulated by spectrally-filtered blue (490 nm), green (525 nm) and red (630 nm) light sti-
muli are shown in Fig 3C to 3E. While all narrow-band spectrally-filtered components evoked
similar inward currents (~15 pA), white light evoked ~30 times higher inward current (Fig 3F).
No statistically significant differences in inward currents were observed between narrow-band
blue, green or red experiments. Light stimulation (0.12 mW/mm2) did not evoke any inward cur-
rents in HEK293 cells without opsin expression (negative control).
In order to confirm broad spectral excitability of white-opsin in the visible spectrum, differ-
ent wavelengths of light ranging from 470 to 640 nm were used, the narrow band spectra of
which were measured using an Ocean Optics spectrometer (Fig 4A). Inward photocurrents of
white-opsin-expressing cells (N = 3 biological replicates, total 18 sweeps per wavelength) were
recorded at different wavelengths of stimulation light and the normalized activation spectrum
is shown in Fig 4B. The data show a high level of activity across a 200 nm range of stimulating
wavelengths, although the maximal activity level ranged from 50% (at longer wavelengths) to
100% (at shorter wavelengths). The reason behind the differences in the activity levels across
the visible spectrum may be attributed to higher efficiency of ChR2 in generating current
(upon blue light activation) as compared to ReaChR (upon red light activation).
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Fig 4. Activation spectrum of white-opsin. (a) Spectra of narrow-band (spectrally-filtered from white light) components measured using Ocean Optics
spectrometer. (b) Normalized activation spectrum of white-opsin. Average ± S.D (N = 3 biological replicates, total 25 sweeps per wavelength). This activation
spectrum is based on the inward current response of patch-clamped HEK293 cells stimulated with different wavelengths of light. a.u. = arbitrary units.
doi:10.1371/journal.pone.0136958.g004
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White-opsin is excited more by broad-band light than narrow-band opsin
For evaluating the enhanced light-sensitivity of white-opsin compared to a narrow-band opsin
like ChR2, HEK293 cells were transfected with ChR2-YFP only. A representative inward cur-
rent response of a ChR2-sensitized HEK293 cell stimulated by white light (at 0.12 mW/mm2)
is shown in Fig 5A. Activation of ChR2-transfected cells by blue, green or red light are shown
in Fig 5B–5D. Similar to white-opsin stimulation (Fig 3), the white light power is fixed and sub-
sequently spectrally-filtered (lower powers for the narrow band measurements) to produce dif-
fering inward peak-currents in ChR2-sensitized cells (Fig 5E). Compared to an ~15 pA current
induced by blue light, green and red light induced small currents of ~5 pA (i.e. the noise level
of our instrument). Although white-light stimulation of ChR2 led to a six-fold increase in pho-
tocurrent compared to blue light, this is significantly lower than that due to white-opsin (30
Fig 5. Spectral-dependent activation of narrow-band ChR2-sensitized cells. Representative inward
current responses of ChR2-sensitized HEK293 cell stimulated by (a) white light, as well as spectrally-filtered
blue (b), green (c) and red (d) components, respectively. The white light power is fixed and then spectrally-
filtered (lower powers for the narrow band measurements). (e) Measured inward peak-currents for varying
spectral excitation of ChR2-sensitized cells. N = 3 biological replicates (total of 4 cells, 18 sweeps).
Average ± S.D. An asterisk (*) represents p<0.05 between blue and other experiments (i.e. green and red).
No statistical difference was found between green and red experiments. There is a significant statistical
difference between white and other experiments (red, blue and green) (#p<0.01). (f) Comparison of
representative white light-induced inward currents in a ChR2-expressing HEK293 cell (blue) with a cell
expressing white-opsin (gray) at same light intensity. WO: white-opsin.
doi:10.1371/journal.pone.0136958.g005
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times enhancement in light-induced current, Fig 3F). This is because ChR2 has a narrower acti-
vation spectrum compared to white-opsin. Further, the inward current evoked by white-light
stimulation was found to be significantly lower in ChR2-sensitized cells than that in the white-
opsin expressing cells at same light intensity (Fig 5F).
Discussion
The ultimate goal in using the broad spectrally-sensitive opsin described in this study is to
enable ambient white-light (~0.01 mW/mm2) to restore vision lost in patients suffering from
retinitis pigmentosa (RP) [28–29]. RP and age-related macular degeneration (AMD) are dis-
eases characterized by marked degeneration of retinal photoreceptors, which hinder vision
through a lack of light-dependent neuronal activation and a cessation of signal transmission to
the visual cortex [29–32]. Cells sensitized with white-opsin show a 30-fold higher photocurrent
compared to those produced by using the spectrally-filtered (blue, green, or red) light compo-
nents only. This 30-fold enhancement in activity can be attributed to the increased bandwidth
(~300 nm vs 10 nm) of white-opsin when excited by broad-band white light. Furthermore,
cells sensitized with white-opsin show a five-fold increase in inward photocurrent responses
compared to cells expressing the narrow-band ChR2 opsin, when stimulated by white light; an
increase that can be primarily attributed once again to the broader bandwidth of white-opsin
(~300 nm) compared to ChR2 (~90 nm). Although it may be argued that three different plas-
mids can be delivered separately to encode three different opsins (with spectrally-distinct λmax
values), the stoichiometric expression of three spectral-components in each cell cannot be
assured as is the case with the fusion protein approach presented here. A limitation may be
that the large size of the white-opsin fusion plasmid may hinder its packaging into a single
adeno-associated virus (AAV) capsid; however, lentiviral vectors allow for capsid packaging of
larger plasmids for delivery to genetically-targeted cells [33]. Also, the use of laser transfection
[34] will allow delivery of such large plasmids to specific cells of interest (e.g. photoreceptors or
inner retinal neurons).
Use of white-opsin, having broad spectral excitability across the visible spectrum, would
facilitate lowering the threshold of white light intensity required to evoke action potentials.
This will lead to higher photosensitivity in higher-order neurons sensitized with white-opsin in
a degenerated retina under ambient white light conditions. Thus, we believe that the use of
white-opsin will minimize light-induced chronic damage to the opsin-expressing cells them-
selves, as well as the residual light-sensing cells that might exist in a diseased or impaired retina.
Although step-function opsins (SFOs) and stable-SFOs provide greater light sensitivity than
other opsins (e.g. ChR2, C1V1, ReaChR), their off-time constants are on the order of tens of
seconds (and even several minutes) instead of milliseconds [35]. By contrast, white-opsin,
while providing higher broad-band sensitivity, has physiologically-relevant on and off rates for
maximal retinal function [36].
By utilizing the whole spectrum, we expect that ambient-light can stimulate white-opsin-
sensitized retinal ganglion cells (RGCs) to generate action potentials. We believe that such
treatment will lead to the restoration of high-resolution vision (as compared to electrical stimu-
lation) by white-light stimulation of white-opsin-sensitized RGCs (or bipolar cells) at ambient
light level. Inclusion of the large dendritic fields produced by RGCs will further lower the
threshold of ambient light intensity required to generate action potentials in cells expressing
white-opsin with white light illumination. This could ultimately eliminate the requirement for
prosthetic devices (e.g. camera based LED/microelectrode-arrays providing active and pat-
terned illumination to the retina) for restoration of vision and lead to higher resolution. Fur-
thermore, there is a need to employ a spatially-targeted delivery method [34] to allow
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expression of the opsin in areas of maximal retinal degeneration (e.g. periphery in RP and mac-
ula in AMD). Therefore, spatially-targeted delivery of white-opsin into higher-order retinal
cells in photo-degenerated retinal regions might allow the restoration of vision under ambient
light conditions. Collectively, this optogenetic tool has the potential to be an important clinical
resource and potential treatment for many retinal diseases.
Supporting Information
S1 Fig. Components of white-opsin.Maps of opsin plasmids cloned via PCR to create attB
sites for the generation of a “white-opsin” expression vector containing three opsins, ChR2,
C1V1, and ReaChR, and the CMV promoter sequence.
(PDF)
S2 Fig. Schematic setup for imaging, stimulation and electrophysiology recording. Cells
expressing narrow-band opsin or white-opsin activated by narrow/broad-band light. WL:
White light source; L: Lens; S1 & 2: Shutter; MO: 40X Microscope objective; FL: Fluorescence
excitation source; DM: Dichroic mirror; Ex: Excitation filter; Em: Emission filter.
(PDF)
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